This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic agents targeting inflammation and pain management. Its structure, featuring a methoxy and trifluoromethyl group, contributes to its efficacy in modulating biological pathways. Additionally, it is employed in research settings for the study of enzyme inhibition and receptor binding activities, aiding in the discovery of new drug candidates. Its applications extend to the fine chemicals sector, where it is used in the production of specialized compounds with potential medicinal properties.